Autor: Sandra Jeleazcov - Seite 2 - Inflammation Research Erlangen

Revolutionary autoimmune therapy now also possible for children and teenagers

A strong interdisciplinary collaboration in #CAR T cell therapy treated a now 16-year-old girl received the immunotherapy as part of an individualised treatment trial at Universitätsklinikum Erlangen as the first child with Lupus worldwide. Systemic Hashtag#Lupus Erythematosus (#SLE) – a…

1st TRR369 DIONE Retreat at Castle Ettersburg

We are thrilled to share highlights from the first retreat of our consortium, TRR369 DIONE #DFG! Last week, our incredible team of researchers gathered to discuss groundbreaking advancements and the future of our research. Key Highlights: Engaging presentations on cutting-edge…

Prof. Schett honoured by Time Magazine

Erlangen immunologist is one of the 100 most influential people in the field of health worldwide Great honour for Prof. Dr Georg Schett, Director of the Medical Clinic 3 – Rheumatology and Immunology at UNiklinikum Erlangen and Vice President of…

A dangerous „date“ of immune cells makes rheumatoid arthritis disappear

A dangerous „date“ of immune cells makes rheumatoid arthritis disappear Appointments don’t always go the way you want them to. Based on this realisation, a team of the Inflammation Research Labs in Erlangen have developed a new therapeutic approach to…

Autor: Sandra Jeleazcov (Seite 2)